Cancers, Vol. 12, Pages 1311: The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?

Conclusion: The MOLES scoring system is a sensitive (99.8%) tool for indicating malignancy in melanocytic choroidal tumors (MOLES ≥ 3). If the examining practitioner can recognize the five features suggestive of malignancy, MOLES is a safe tool to optimize referral of melanocytic choroidal tumors for specialist care.

Source: Cancers - May 20, 2020 Category: Cancer & Oncology Authors: Kelsey A. Roelofs Roderick O ’Day Lamis Al Harby Amit K. Arora Victoria M.L. Cohen Mandeep S. Sagoo Bertil Damato Tags: Article Source Type: research